Kuiper, Johan
Leiden University
5 papers on CoChatORCID 0000-0001-5834-690X
Most cited papers
- Verified
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report
van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology
Inflammasome and immune disordersAtherosclerosis and Cardiovascular Diseases
Cited by 348
- Verified
Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis
Seijkens, T. T. P., van Tiel, C. M., Kusters, P. J. H., Atzler, D., Soehnlein, O., Zarzycka, B., Aarts, S. A. B. M., Lameijer, M., Gijbels, M. J., Beckers, L., et al. (2018) · Journal of the American College of Cardiology
Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism
Cited by 195
- Verified
Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality
Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry
Sepsis Diagnosis and TreatmentImmune Response and Inflammation
Cited by 186
- Verified
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
Rensen, P. C., Oosten, M., Bilt, E., Eck, M., Kuiper, J., & Berkel, T. J. (1997) · Journal of Clinical Investigation
Immune Response and InflammationNanoparticle-Based Drug Delivery
Cited by 113
- Verified
The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status
Hoekstra, M., Li, Z., Kruijt, J. K., Eck, M. V., Berkel, T. J. C. V., & Kuiper, J. (2010) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLipid metabolism and biosynthesis
Cited by 108
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free